{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T13:30:58Z","timestamp":1749475858071,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00198-024-07159-5","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:02:36Z","timestamp":1719900156000},"page":"1779-1787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study"],"prefix":"10.1007","volume":"35","author":[{"given":"So Young","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Hwan","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunmee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Kyung","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2452-8419","authenticated-orcid":false,"given":"Se Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Epidemiology Committee of the Korean Society of Bone Metabolism","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"7159_CR1","doi-asserted-by":"crossref","unstructured":"Becker DE (2013) Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog Spring 60(1):25\u201331; quiz 2","DOI":"10.2344\/0003-3006-60.1.25"},{"key":"7159_CR2","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2147\/DDDT.S148654","volume":"13","author":"ZA Yanbeiy","year":"2019","unstructured":"Yanbeiy ZA, Hansen KE (2019) Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. Drug Des Devel Ther 13:2843\u20132852","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"7159_CR3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1590\/S0004-27302007000800028","volume":"51","author":"G Mazziotti","year":"2007","unstructured":"Mazziotti G, Giustina A, Canalis E, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. Arq Bras Endocrinol Metabol 51(8):1404\u20131412","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"7159_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00223-012-9630-5","volume":"91","author":"R Rizzoli","year":"2012","unstructured":"Rizzoli R, Adachi JD, Cooper C, Dere W, Devogelaer JP, Diez-Perez A et al (2012) Management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 91(4):225\u2013243","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"7159_CR5","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP Van Staa","year":"2003","unstructured":"Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224\u20133229","journal-title":"Arthritis Rheum"},{"issue":"10","key":"7159_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP van Staa","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13(10):777\u2013787","journal-title":"Osteoporos Int"},{"issue":"6","key":"7159_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15(6):993\u20131000","journal-title":"J Bone Miner Res"},{"issue":"4","key":"7159_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.11005\/jbm.2018.25.4.195","volume":"25","author":"SY Park","year":"2018","unstructured":"Park SY, Gong HS, Kim KM, Kim D, Kim HY, Jeon CH et al (2018) Korean guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. J Bone Metab 25(4):195\u2013211","journal-title":"J Bone Metab"},{"issue":"3","key":"7159_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3803\/EnM.2020.659","volume":"35","author":"JW Koh","year":"2020","unstructured":"Koh JW, Kim J, Cho H, Ha YC, Kim TY, Lee YK et al (2020) Effects of systemic glucocorticoid use on fracture risk: a population-based study. Endocrinol Metab (Seoul) 35(3):562\u2013570","journal-title":"Endocrinol Metab (Seoul)"},{"key":"7159_CR10","doi-asserted-by":"crossref","unstructured":"de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56(3):221\u2013229","DOI":"10.1016\/S0895-4356(02)00585-1"},{"issue":"5","key":"7159_CR11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00198-015-3455-9","volume":"27","author":"MA Amiche","year":"2016","unstructured":"Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Levesque LE, Adachi JD et al (2016) Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. Osteoporos Int 27(5):1709\u20131718","journal-title":"Osteoporos Int"},{"key":"7159_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bone.2018.09.004","volume":"117","author":"DE Robinson","year":"2018","unstructured":"Robinson DE, van Staa TP, Dennison EM, Cooper C, Dixon WG (2018) The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: a cohort study. Bone 117:83\u201390","journal-title":"Bone"},{"issue":"9","key":"7159_CR13","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00198-013-2352-3","volume":"24","author":"SR Majumdar","year":"2013","unstructured":"Majumdar SR, Morin SN, Lix LM, Leslie WD (2013) Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int 24(9):2493\u20132498","journal-title":"Osteoporos Int"},{"issue":"8","key":"7159_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/acr.23279","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE et al (2017) 2017 American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 69(8):1095\u20131110","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7159_CR15","doi-asserted-by":"crossref","unstructured":"Messina OD, Vidal M, Torres JAM, Vidal LF, Arguissain C, Pereira RM et al (2022) Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update : this manuscript has been produced under the auspices of the Committee of National Societies (CNS) and the Committee of Scientific Advisors (CSA) of the International Osteoporosis Foundation (IOF). Aging Clin Exp Res 34(11):2591\u20132602","DOI":"10.1007\/s40520-022-02261-2"},{"issue":"3","key":"7159_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Johansson H, Oden A, McCloskey EV (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22(3):809\u2013816","journal-title":"Osteoporos Int"},{"key":"7159_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fphar.2017.00625","volume":"8","author":"SW Lai","year":"2017","unstructured":"Lai SW, Lin CL, Liao KF (2017) Use of oral corticosteroids and risk of hip fracture in the elderly in a case-control study. Front Pharmacol 8:625","journal-title":"Front Pharmacol"},{"issue":"3","key":"7159_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3928\/19404921-20160908-01","volume":"10","author":"HW Lach","year":"2017","unstructured":"Lach HW, Harrison BE, Phongphanngam S (2017) Falls and fall prevention in older adults with early-stage dementia: an integrative review. Res Gerontol Nurs 10(3):139\u2013148","journal-title":"Res Gerontol Nurs"},{"key":"7159_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12883-014-0175-2","volume":"14","author":"HK Wang","year":"2014","unstructured":"Wang HK, Hung CM, Lin SH, Tai YC, Lu K, Liliang PC et al (2014) Increased risk of hip fractures in patients with dementia: a nationwide population-based study. BMC Neurol 14:175","journal-title":"BMC Neurol"},{"issue":"5","key":"7159_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/jgs.12209","volume":"61","author":"T Kvelde","year":"2013","unstructured":"Kvelde T, McVeigh C, Toson B, Greenaway M, Lord SR, Delbaere K et al (2013) Depressive symptomatology as a risk factor for falls in older people: systematic review and meta-analysis. J Am Geriatr Soc 61(5):694\u2013706","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"7159_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1164\/rccm.200310-1349OC","volume":"170","author":"PD Scanlon","year":"2004","unstructured":"Scanlon PD, Connett JE, Wise RA, Tashkin DP, Madhok T, Skeans M et al (2004) Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med 170(12):1302\u20131309","journal-title":"Am J Respir Crit Care Med"},{"issue":"9213","key":"7159_CR22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","volume":"355","author":"CA Wong","year":"2000","unstructured":"Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R et al (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355(9213):1399\u20131403","journal-title":"Lancet"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07159-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T23:03:16Z","timestamp":1727391796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07159-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7159"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07159-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"23 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"So Young Park, Seong Hee Ahn, Bae Gi Hwan, Sunmee Jang, Mi Kyung Kwak, Ha Young Kim, and Se Hwa Kim declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}